Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma
Journal of Clinical Oncology, 07/18/2012
Clinical Article
Sonneveld P et al. – Bortezomib during induction and maintenance improves Complete response (CR) and achieves superior progression–free survival (PFS) and overall survival (OS).



